Gupta P, Godfrey E, Schultz K, Qiao L, Aguirre N, Bader J, Foote M, Shen J, Shergill A, Cecchini M, Sundar R, Sheltzer J, Turaga K. Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Annals Of Surgical Oncology 2026, 1-6. PMID: 41634518, DOI: 10.1245/s10434-025-19057-z.
Peer-Reviewed Original Research
This study investigates drug sensitivity in colorectal cancer peritoneal metastases, showing CMS4 tumors respond better to mitomycin-C and irinotecan, informing personalized chemotherapy strategies.